#794 caresyntax and Insel Gruppe AG Launch Collaboration to Automate and Standardize Surgical Skills Assessment Using AI and Machine Learning
#795 ProBioGen licenses GlymaxX® Technology to Bayer
#796 ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology
#797 Asahi Kasei Pharma contracts ProBioGen for the Advancement of their Biologics Pipeline
#798 Fine-tuning communication: How drugs and diseases influence signals between nerve cells
#799 ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule
#800 Alrise announces acquisition of its ImSus® drug delivery technology by Ferring International Center S.A.
#801 Fine-tuning gene scissors: Computer model for adjusting CRISPR-Cas9 enables more precise cuts in the genome
#802 Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care
#803 Recognise and control new variants of the deadly Ebola virus more quickly
#804 Progress towards an MVP to globally benchmark AI symptom assessments
#805 ProBioGen licenses GlymaxX® Technology to AbbVie
#806 Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical’s targeted CAIX radiotherapy
#807 Open innovation challenge for Sustainable materials solutions
#808 Myelo Therapeutics Awarded NIH-NIAID Contract Valued up to $6 Million over 3 Years for Development of Myelo001 as Treatment for Acute Radiation Syndrome
#809 The start up accelerator for advanced materials
#810 Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China
#811 THE DANGEROUS DUAL ROLE OF THE IMMUNE SYSTEM IN COVID-19
#812 First-in-human clinical study results
#813 Targeted deep brain stimulation to treat obsessive-compulsive disorder
#814 ProBioGen licenses GlymaxX® Technology to Sanofi
#815 Charité Dean Axel Pries to be new president of World Health Summit from 2021 on
#816 Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1
#817 Milestones to success: how to turn research into health
#818 Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA
#819 ProBioGen enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project
#820 Asher Biotherapeutics contracts ProBioGen to develop and manufacture their Lead Candidate
#821 Global Innovation Collaborative
#822 Learnings from Covid-19 & Partnership Opportunities with Bayer G4A
#823 ProBioGen and Minapharm incorporate subsidiary
#824 Seed round oversubscribed: Bluu Biosciences secures €7 million – Europe's first cell-based fish biotech company takes off
#825 Myelo Therapeutics Receives Additional NIAID Funding to Advance Development of Myelo001 for Acute Radiation Syndrome
#826 Eckert & Ziegler and Telix Pharmaceuticals Enter Co-Promotion Agreement for Prostate Cancer Diagnostic in the United States
#827 Eckert & Ziegler Takes over Brazilian Isotope Specialists - Strengthening their Presence in South America
#828 Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®
#829 Eckert & Ziegler Acquires 53,000 Square Feet Facility for Expansion of Contract Development and Manufacturing Services
#830 MedTech startup Smarterials Technology closes second seed financing round
#831 Berliner Startup Stipendium – New call for a Sustainable City
#832 Nantes University Hospital Doses First Patients with Eckert & Ziegler's Novel Ga-68 Imaging Agent PENTIXAFOR
#833 Eckert & Ziegler Acquires Property for Radiopharmaceutical Production Site in China
#834 Ada Health announces partnership with AXA OneHealth
#835 Noxxon secures €17 million expansion of equity-linked facility with atlas to advance nox-a12 in glioblastoma and pancreatic cancer programs
#836 Eckert & Ziegler Signs Exclusive Supply Agreement for Ytterbium-176
#837 German Chancellor delighted after company visit to KNAUER, calling the company a pearl
#838 Insulin Directly Regulates the Circadian Clock in Adipose Tissue
#839 Gates Foundation: commitment to global health
#840 An indispensable pitstop for the gene copy machine
#841 Charité develops a ‘Health Data Cloud‘ with EBRAINS to help shape the European Health Data Space
#842 Imvaq Therapeutics signs a Service and Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform
#843 The tricks of lymphomas
#844 Food tech startup Perfeggt – The egg without chicken – raises 2.8 million USD
#845 BIOTRONIK Patient App Facilitates Digital Patient Engagement
#846 Artificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros
#847 Eckert & Ziegler with Record Results in FY 2021 and Positive Outlook
#848 Eckert & Ziegler Acquires Argentinian SPECT Specialist
#849 German National Cohort data accessible for research
#850 Charité researchers identify key signaling pathway involved in Lymphoma tumor formation
#851 Combination is key – new treatments for lung and colon cancer?
#852 Apply for the Creative Destruction Lab (CDL) Program
#853 Max Planck Institute for Molecular Genetics (MPIMG) decoded epigenetic mechanisms for parent-specific genetic activation
#854 ProBioGen signs a commercial license agreement with AstraZeneca providing their GlymaxX®
#855 Corona: New Insights into Antibody Response against Viral Variants
#856 Researchers from Charité and MDC discover reasons for treatment resistance of multiple myeloma
#857 Glycotope to spin-out its Service Business to the newly formed FyoniBio GmbH
#858 Female Founders Award 2023 | Apply or Nominate Now!
#859 Startup Pitch Competition on April 28 - SelectUSA Investment Summit
#860 Eckert & Ziegler Submits Drug Master File for Lu-177 n.c.a.
#861 Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market
#862 Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
#863 Free service for medical AI researchers: AskPaper.ai
#864 Microbial cooperation as one of the causes of drug tolerance in fungal infections discovered by Charité researchers
#865 Insertable Cardiac Monitors (ICM) and Remote Monitoring May Improve Outcomes for Post-Myocardial Infarction Patients, Study Demonstrates
#866 Combination of wearable data and digital questionnaires: FeMFit study by Data4Life opens up new paths in research on female health
#867 PEI Regulatory Approval Received for Government Funded (€ 7.4 Million) Clinical Trial Investigating Adrenomed’s Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients
#868 Charité researchers identified a large number of specific genes which play a key role in the onset and development of schizophrenia
#869 Eckert & Ziegler: Radboud University Medical Center Netherlands to Image First Patient with PENTIXAFOR
#870 Charité and MDC discover how a bacterial infection causes tissue changes in gastric inflammation
#871 Charité researchers secure two new ERC Consolidator Grants
#872 Dr. Lutz Hilbrich, Chief Executive Officer at ProBioGen (and the subsidiary MiGenTra) and Andrea Hauptmann, Chief Financial Officer at ProBioGen (and the subsidiary MiGenTra)
#873 Memorandum signed on establishing a center of gene and cell therapy
#874 Bluu Seafood, Europe's pioneer in cultivated fish. kick off strategic partnership with CellX, China's pioneer in cultivated meat
#875 LABORATORY EQUIPMENT SPECIALIST KNAUER WANTED TO HELP SAVE THE WORLD AND NOW RECEIVED GERMAN INNOVATION AWARD
#876 Eckert & Ziegler Receives Environmental Approval for Jintan Radioisotope Site
#877 Lutz Hilbrich Appointed as Senator to the Senate of Economy Europe
#878 Glycotope Presents Glyco-Engineered Cell Lines at the 2023 American Association for Cancer Research (AACR) Meeting
#879 BIH researchers discovered a mechanism keeps stem cells intact for a lifetime
#880 Interview | Prof. Dr. Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens (MPUSP)
#881 MDC researchers have created protein maps of tumors that aim at finding therapies for resistant tumors
#882 MDC researcher has described how sensory neurons near the central canal in the spinal cord help regulate motor functions
#883 Using an app to combat skin conditions: Nia Health receives millions in funding
#884 Eckert & Ziegler Becomes Contract Manufacturer for Clinical Development Candidates Based on Lutetium-177 and Actinium-225
#885 LegoChem Biosciences and Glycotope announce research collaboration and license agreement for an antibody for use as antibody drug conjugate
#886 How to find marker genes in cell clusters
#887 MDC research team discovered how zebrafish can regenerate heart tissue
#888 MDC researchers discovered how molecular boundaries across the genome work
#889 Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
#890 Bayer proudly sponsors BIO-EUROPES Startup-Spotlight – Apply to Pitch!
#891 International consortium including MDC brings together 7,200 segments of the human genome that are virtually unexplored
Show more items